Industry & Business

Aerie Pharmaceuticals to Establish Athlone Manufacturing Plant

 Breaking News
  • Neueda Technologies Establishing a Software Engineering Hub in Athlone Neueda Technologies, a privately-owned IT Training, development and consulting services company headquartered in Belfast, is establishing a Software Engineering Hub in Athlone, Co. Westmeath, employing 200 staff over four years. The project is supported by the Irish Government through IDA Ireland. The company will undertake software development services for global telecommunications and financial services clients at [...]...
  • Progress at Last! – British Irish Chamber Welcomes UK White Paper on Brexit The British Irish Chamber of Commerce has welcomed the publication of the white paper on Brexit by the UK Government but has called for a full agreement on services to be sought.   Commenting after the publication of the white paper, John McGrane, the Director-General of the British Irish Chamber of Commerce, said: “At last we [...]...
  • Fexco to Create 175 New Jobs in Ireland’s South West Irish-international fintech company, Fexco has announced a significant expansion of its operations headquartered in Killorglin, Co Kerry creating 175 new jobs over 3 years. The jobs form part of Fexco’s expansion strategy reinforcing the South West’s position as the driving force of Ireland’s fintech industry. The announcement was made in Killorglin by Julie Sinnamon, CEO of [...]...
  • Reliance on UK Exports Could Lead to High Brexit Cost Increases For Irish Firms Irish-owned firms rely heavily on the UK as the source of intermediate inputs, which are goods used to produce a final product. Over half of the total imports used by Irish-owned firms are sourced in the UK with many importing solely from the UK market. Many Irish-owned companies are therefore highly exposed to cost increases [...]...
  • Center Parcs Serves Up €5.2 Million in Contracts to Irish Food Companies Four of Ireland’s top food companies will benefit from a significant boost to their businesses as Center Parcs announces the awarding of food supplier contracts to its Center Parcs Longford Forest resort – due to open in summer 2019 – worth a combined total of €5.2 million. Center Parcs has awarded the following food supplier contracts: Dublin [...]...

Aerie Pharmaceuticals to Establish Athlone Manufacturing Plant

Aerie Pharmaceuticals to Establish Athlone Manufacturing Plant
January 13
12:18 2017

Aerie Pharmaceuticals, Inc. announced on Monday that they have entered into a lease agreement with IDA Ireland to establish a new manufacturing plant in the recently-constructed 2,650 square meter IDA Advanced Technology Building in Athlone, Ireland.

Aerie has commenced equipment ordering and will begin internal construction immediately. Estimated project-wide construction and equipment costs are expected to total approximately $25 million (excluding ongoing labor-related and lease expenses), of which approximately $16 million is expected to be spent in 2017. If approved, commercial product supply of Rhopressa from the plant is expected to be available by 2020.

The Athlone facility will house Aerie’s first manufacturing plant, which is expected to produce commercial supplies for Aerie’s current product candidates, Rhopressa and Roclatan. If approved, these products are expected to offer the first new mechanisms of action for treatment of patients with glaucoma in some 20 years.

“We have now achieved another milestone in executing our stated long-term strategy,” Aerie Chief Executive Officer Vicente Anido, Jr. said. “As we prepare for commercialization, it is increasingly important that we ensure greater independence regarding our finished product sourcing while also meaningfully reducing our future product costs. We are grateful to our IDA colleagues in Ireland for their cooperation throughout this process and the incentives that we have been granted.”

Aerie has commenced equipment ordering and will begin internal construction immediately. Estimated project-wide construction and equipment costs are expected to total approximately €25 million (excluding ongoing labor-related and lease expenses), of which approximately €16 million is expected to be spent in 2017. If approved, commercial product supply of Rhopressa from the plant is expected to be available by 2020. The company will initially create up to 50 new jobs in sterile manufacturing, quality, engineering and other support capabilities.

“The Midlands is a fantastic place to invest, and Aerie’s choice to locate its manufacturing facility in IDA Ireland’s new building there is particularly welcome,” Minister for Jobs, Enterprise and Innovation Mary Mitchell O’Connor said. “As we pass the 200,000 mark for people employed in overseas companies in Ireland, we need to continue to ensure a good spread of jobs throughout the regions.

About Author

editor

editor

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4